Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001) Meeting Abstract


Authors: Mansfield, A. S.; Goodrich, A.; Foster, N. R.; Savvides, P.; Villaruz, L. C.; Forde, P. M.; Raghav, K. P. S.; Romesser, P. B.; Feldman, D.; Cao, L.; Salvatore, M. M.; Roden, A. C.; Powell, S. F.; Shergill, A.; Munster, P. N.; Schwartz, G. K.; Grotz, T. E.
Abstract Title: Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001)
Meeting Title: 2023 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 16 Suppl.
Meeting Dates: 2023 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-06-01
Language: English
DOI: 10.1200/JCO.2023.41.16_suppl.TPS8603
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: TPS8603 -- Meeting was also available virtually -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Bernard Romesser
    189 Romesser